Company intelligence / Profile preview

Artelo Biosciences

Solana Beach, California, United Statesartelobio.com ↗

Ownership: Public · ARTLW
Development stage: Phase 1

Overview

Artelo has three main clinical programs. ART26.12, a first-in-class selective FABP5 inhibitor for painful neuropathies, completed its first cohort in a Phase I trial with further results expected in mid–2025. ART27.13, originally developed by AstraZeneca, showed statistically significant weight gain in prior studies and is now in a Phase II trial for cancer-related anorexia/cachexia syndrome. ART12.11, a proprietary cannabidiol cocrystal composition with improved pharmacokinetics over standard CBD formulations, has shown promising nonclinical results; human studies are planned for late–2025.[3][6][8] No commercial products yet.

Therapeutic areas: OncologyEndocrinologyNeurologyRheumatology
Modalities: Small molecules (including cocrystals and selective inhibitors)[3][8]
Industry: Biotech

Drug pipeline

3 assets

ART12.11

Preclinical

2 more assets in the full pipeline.

Request access →

Partnerships

Worldwide Clinical Trials CRO partner for clinical trials of ART26.12 [9]

Financials

Market cap: $13.1K
Total revenue: $0
Enterprise value: $-4.1M

Beyond the preview

Go deeper on Artelo Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artelo Biosciences.

Explore the full profile